BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 043709
(253 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/117 (40%), Positives = 69/117 (58%), Gaps = 5/117 (4%)
Query: 26 FSLASISAATDNFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLE-EFKNEMM 81
FSL + A+DNFS +N LG GGFG G+L +G VAVKRL + QG E +F+ E+
Sbjct: 28 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 82 LIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFD-PANKGRLGWGTRVRI 137
+I+ NL+R+ G C+ ++L+Y +M N S+ L + P ++ L W R RI
Sbjct: 88 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 138 YALHGVFSIKSDVFSFGVLLLETLSSKKN---AHFYNTNSLTLLGYVIWNLWNDGSLWDL 194
Y G S K+DVF +GV+LLE ++ ++ A N + + LL +V L + L L
Sbjct: 214 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-GLLKEKKLEAL 272
Query: 195 MDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
+D LQ +++ V L C + + +RP M E+V ML +
Sbjct: 273 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 74.7 bits (182), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 68/117 (58%), Gaps = 5/117 (4%)
Query: 26 FSLASISAATDNFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLE-EFKNEMM 81
FSL + A+DNF +N LG GGFG G+L +G VAVKRL + QG E +F+ E+
Sbjct: 20 FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 82 LIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFD-PANKGRLGWGTRVRI 137
+I+ NL+R+ G C+ ++L+Y +M N S+ L + P ++ L W R RI
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 138 YALHGVFSIKSDVFSFGVLLLETLSSKKN---AHFYNTNSLTLLGYVIWNLWNDGSLWDL 194
Y G S K+DVF +GV+LLE ++ ++ A N + + LL +V L + L L
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-GLLKEKKLEAL 264
Query: 195 MDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
+D LQ +++ V L C + + +RP M E+V ML +
Sbjct: 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 60.5 bits (145), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 23 IPFFS----LASISAATDNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEE 75
+PF S L + AT+NF + +G G FG G L +G +VA+KR + +S QG+EE
Sbjct: 22 VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 76 FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLF-DPANKGRLGWGTR 134
F+ E+ ++ + +LV +IG C E+ ILIY++M N +L L+ + W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 135 VRI--------YALHGVFSIKSDVFSFGVLLLETLSSK 164
+ I + LH I DV S +LL E K
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPK 179
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 23 IPFFS----LASISAATDNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEE 75
+PF S L + AT+NF + +G G FG G L +G +VA+KR + +S QG+EE
Sbjct: 22 VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 76 FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLF-DPANKGRLGWGTR 134
F+ E+ ++ + +LV +IG C E+ ILIY++M N +L L+ + W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 135 VRI--------YALHGVFSIKSDVFSFGVLLLETLSSK 164
+ I + LH I DV S +LL E K
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPK 179
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 26 FSLASISAATDNFSME------NKLGEGGFGP--GKLLNGEQVAVKRLSSQSGQGLEE-- 75
FS + T+NF NK+GEGGFG +N VAVK+L++ EE
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 76 --FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGT 133
F E+ ++AK Q NLV ++G + L+Y +MPN SL L L W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 134 RVRIYA--------LHGVFSIKSDVFSFGVLLLETLSSK 164
R +I LH I D+ S +LL E ++K
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 173
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 2/98 (2%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPM 198
AL G + KSD++SFGV+LLE ++ + L LL + ++ D +D
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKK 264
Query: 199 LQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
+ S + YS V C E RP + ++ +L
Sbjct: 265 MNDADSTSVEAMYS-VASQCLHEKKNKRPDIKKVQQLL 301
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 26 FSLASISAATDNFSME------NKLGEGGFGP--GKLLNGEQVAVKRLSSQSGQGLEE-- 75
FS + T+NF NK+GEGGFG +N VAVK+L++ EE
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 76 --FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGT 133
F E+ ++AK Q NLV ++G + L+Y +MPN SL L L W
Sbjct: 69 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 134 RVRIYA--------LHGVFSIKSDVFSFGVLLLETLSSK 164
R +I LH I D+ S +LL E ++K
Sbjct: 129 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 167
Score = 34.7 bits (78), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 2/98 (2%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPM 198
AL G + KSD++SFGV+LLE ++ + L LL + ++ D +D
Sbjct: 200 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKK 258
Query: 199 LQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
+ S + YS V C E RP + ++ +L
Sbjct: 259 MNDADSTSVEAMYS-VASQCLHEKKNKRPDIKKVQQLL 295
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 26 FSLASISAATDNFSME------NKLGEGGFGP--GKLLNGEQVAVKRLSSQSGQGLEE-- 75
FS + T+NF NK+GEGGFG +N VAVK+L++ EE
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 76 --FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGT 133
F E+ ++AK Q NLV ++G + L+Y +MPN SL L L W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 134 RVRIYA--------LHGVFSIKSDVFSFGVLLLETLSSK 164
R +I LH I D+ S +LL E ++K
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 173
Score = 34.7 bits (78), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 2/98 (2%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPM 198
AL G + KSD++SFGV+LLE ++ + L LL + ++ D +D
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKK 264
Query: 199 LQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
+ S + YS V C E RP + ++ +L
Sbjct: 265 MNDADSTSVEAMYS-VASQCLHEKKNKRPDIKKVQQLL 301
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/159 (31%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 26 FSLASISAATDNFSME------NKLGEGGFGP--GKLLNGEQVAVKRLSSQSGQGLEE-- 75
FS + T+NF NK GEGGFG +N VAVK+L++ EE
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 76 --FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGT 133
F E+ + AK Q NLV ++G + L+Y + PN SL L L W
Sbjct: 66 QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 134 RVRIYA--------LHGVFSIKSDVFSFGVLLLETLSSK 164
R +I LH I D+ S +LL E ++K
Sbjct: 126 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAK 164
Score = 34.3 bits (77), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 2/98 (2%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPM 198
AL G + KSD++SFGV+LLE ++ + L LL + ++ D +D
Sbjct: 197 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKK 255
Query: 199 LQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
S + YS V C E RP + ++ +L
Sbjct: 256 XNDADSTSVEAXYS-VASQCLHEKKNKRPDIKKVQQLL 292
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 37 NFSMENKLGEGGFGPGKL-----LNGEQ----VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 87
N ++ +LGEG FG L L EQ VAVK L S ++F E L+ LQ
Sbjct: 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
++V+ G CVE I+++E+M + L+ FL
Sbjct: 74 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 106
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 39/110 (35%), Positives = 58/110 (52%), Gaps = 16/110 (14%)
Query: 44 LGEGGFGPGKLL--------NGEQVAVKRLSSQSG-QGLEEFKNEMMLIAKLQDINLVRI 94
LGEG FG +L GEQVAVK L +SG + + K E+ ++ L N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 95 IGCCVEK---GVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALH 141
G C E G+K LI E +P+ SL +L P NK ++ +++ YA+
Sbjct: 89 KGICTEDGGNGIK-LIMEFLPSGSLKEYL--PKNKNKINLKQQLK-YAVQ 134
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 39/110 (35%), Positives = 58/110 (52%), Gaps = 16/110 (14%)
Query: 44 LGEGGFGPGKLL--------NGEQVAVKRLSSQSG-QGLEEFKNEMMLIAKLQDINLVRI 94
LGEG FG +L GEQVAVK L +SG + + K E+ ++ L N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 95 IGCCVEK---GVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALH 141
G C E G+K LI E +P+ SL +L P NK ++ +++ YA+
Sbjct: 77 KGICTEDGGNGIK-LIMEFLPSGSLKEYL--PKNKNKINLKQQLK-YAVQ 122
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 17 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 20 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 15 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 21 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 22 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 23 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 83 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 19 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 14/123 (11%)
Query: 12 TEARGKSKESCI----PFFSLASISA-ATDNFSMENKLGEGGFGPGKL-----LNGEQ-- 59
TE +G + I +FS A + + ++ +LGEG FG L L EQ
Sbjct: 12 TEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDK 71
Query: 60 --VAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLD 117
VAVK L S ++F+ E L+ LQ ++VR G C E ++++E+M + L+
Sbjct: 72 MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 118 YFL 120
FL
Sbjct: 132 RFL 134
Score = 28.1 bits (61), Expect = 5.2, Method: Compositional matrix adjust.
Identities = 13/35 (37%), Positives = 22/35 (62%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNS 174
L+ F+ +SDV+SFGV+L E + K + +N+
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 10/89 (11%)
Query: 42 NKLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 34 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 94 IIGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E++P SL +L
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 37 NFSMENKLGEGGFGPGKL-----LNGEQ----VAVKRLSSQSGQGLEEFKNEMMLIAKLQ 87
+ ++ +LGEG FG L L EQ VAVK L S ++F+ E L+ LQ
Sbjct: 13 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 72
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
++VR G C E ++++E+M + L+ FL
Sbjct: 73 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 105
Score = 28.5 bits (62), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 18/140 (12%)
Query: 41 ENKLGEGG--FGPGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINL-VRIIGC 97
+ KL GG PG L G+ +AV +SQ G M+ +A L ++ + C
Sbjct: 111 DAKLLAGGEDVAPGPLGLGQLLAV---ASQVAAG-------MVYLAGLHFVHRDLATRNC 160
Query: 98 CVEKGVKILIYEHMPNK---SLDYFLFDPANKGRLGWGTRVRIYALHGVFSIKSDVFSFG 154
V +G+ + I + ++ S DY+ + W I L+ F+ +SDV+SFG
Sbjct: 161 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFG 218
Query: 155 VLLLETLSSKKNAHFYNTNS 174
V+L E + K + +N+
Sbjct: 219 VVLWEIFTYGKQPWYQLSNT 238
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 43 KLGEGGFGPGKL-----LNGEQ----VAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+LGEG FG L L EQ VAVK L S ++F+ E L+ LQ ++VR
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 94 IIGCCVEKGVKILIYEHMPNKSLDYFL 120
G C E ++++E+M + L+ FL
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFL 111
Score = 28.5 bits (62), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 18/140 (12%)
Query: 41 ENKLGEGG--FGPGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINL-VRIIGC 97
+ KL GG PG L G+ +AV +SQ G M+ +A L ++ + C
Sbjct: 117 DAKLLAGGEDVAPGPLGLGQLLAV---ASQVAAG-------MVYLAGLHFVHRDLATRNC 166
Query: 98 CVEKGVKILIYEHMPNK---SLDYFLFDPANKGRLGWGTRVRIYALHGVFSIKSDVFSFG 154
V +G+ + I + ++ S DY+ + W I L+ F+ +SDV+SFG
Sbjct: 167 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFG 224
Query: 155 VLLLETLSSKKNAHFYNTNS 174
V+L E + K + +N+
Sbjct: 225 VVLWEIFTYGKQPWYQLSNT 244
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 43 KLGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRI 94
+LG+G FG P + GE VAVK+L + + L +F+ E+ ++ LQ N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 95 IGCCVEKGVK--ILIYEHMPNKSLDYFL 120
G C G + LI E +P SL +L
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 12/96 (12%)
Query: 36 DNFSMENKLGEGGFG-------PGKLLNGEQ---VAVKRLSSQSGQGLE-EFKNEMMLIA 84
+N +GEG FG PG LL E VAVK L ++ ++ +F+ E L+A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPG-LLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 85 KLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N+V+++G C L++E+M L+ FL
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 207 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 255
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 256 --NCP--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-HPSFPEVSFF 300
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 204 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 252
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 253 --NCP--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-HPSFPEVSFF 297
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 206 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 254
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 255 --NCP--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-HPSFPEVSFF 299
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 207 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 255
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 256 --NCP--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-HPSFPEVSFF 300
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 208 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 256
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 257 --NCP--ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL-HPSFPEVSFF 301
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 207 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 255
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 256 --NCP--ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL-HPSFPEVSFF 300
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 207 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 255
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 256 --NCP--ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL-HPSFPEVSFF 300
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 16/110 (14%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SD++SFGV+L E ++S + ++ +L +V+ DG D D
Sbjct: 207 GVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVM-----DGGYLDQPD----- 255
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLPYPQQSAF 251
+ P +R +++ C++ N RPT LEIV++L +++ + +P+ S F
Sbjct: 256 --NCP--ERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL-HPSFPEVSFF 300
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + + E+F E ++ KL LV++ G C
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L++E M + L +L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
Score = 35.0 bits (79), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS V+ ++ + + L P L +
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI---STGFRLYKPRLASTH 232
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y I+ C++E DRP ++ L+
Sbjct: 233 VYQIMNH-------CWKERPEDRPAFSRLLRQLA 259
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 37 NFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAK 85
+ ++ +LGEG FG P K + VAVK L + ++F+ E L+
Sbjct: 16 DIVLKRELGEGAFGKVFLAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTN 73
Query: 86 LQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
LQ ++V+ G C + I+++E+M + L+ FL
Sbjct: 74 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 20/31 (64%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNS 174
F+ +SDV+SFGV+L E + K F +N+
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + + E+F E ++ KL LV++ G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L++E M + L +L
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYL 91
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS V+ ++ + + L P L +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI---STGFRLYKPRLASTH 230
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y I+ C++E DRP ++ L+
Sbjct: 231 VYQIMNH-------CWKERPEDRPAFSRLLRQLAE 258
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + + E+F E ++ KL LV++ G C
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L++E M + L +L
Sbjct: 75 LEQAPICLVFEFMEHGCLSDYL 96
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS + + + + L P L +
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--------DISTGFRLYKPRLASTH 235
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y I+ C+RE DRP ++ L+
Sbjct: 236 VYQIMNH-------CWRERPEDRPAFSRLLRQLAE 263
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + + E+F E ++ KL LV++ G C
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L++E M + L +L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS V+ ++ + + L P L +
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI---STGFRLYKPRLASTH 232
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y I+ C++E DRP ++ L+
Sbjct: 233 VYQIMNH-------CWKERPEDRPAFSRLLRQLAE 260
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 49 FGPGKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILI 107
FGP + VA+K L ++ G EEF++E ML A+LQ N+V ++G + +I
Sbjct: 31 FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 90
Query: 108 YEHMPNKSLDYFL 120
+ + + L FL
Sbjct: 91 FSYCSHGDLHEFL 103
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 18/23 (78%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
++G FSI SD++S+GV+L E S
Sbjct: 203 MYGKFSIDSDIWSYGVVLWEVFS 225
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 24/73 (32%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 49 FGPGKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILI 107
FGP + VA+K L ++ G EEF++E ML A+LQ N+V ++G + +I
Sbjct: 48 FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107
Query: 108 YEHMPNKSLDYFL 120
+ + + L FL
Sbjct: 108 FSYCSHGDLHEFL 120
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 18/23 (78%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
++G FSI SD++S+GV+L E S
Sbjct: 220 MYGKFSIDSDIWSYGVVLWEVFS 242
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 180 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 231
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 232 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 262
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 9 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 67
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 68 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 98
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 243
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 244 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 274
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 21 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 79
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 80 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 110
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 230
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 231 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 261
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 8 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 66
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 67 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 97
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 241
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 242 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 19 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 78 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 108
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 245
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 246 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 276
Score = 35.0 bits (79), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 23 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 81
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 82 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 112
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 235
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 236 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266
Score = 32.0 bits (71), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G G G +VAVK L Q + F E L+ +LQ LV
Sbjct: 13 ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 102
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 235
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 236 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266
Score = 35.0 bits (79), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 102
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 244
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 245 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 275
Score = 35.0 bits (79), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 22 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 80
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 81 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 111
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 25/102 (24%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNS--LTLL--GYVIWNLWN-DGSLWDLMD 196
G F+IKSDV+SFG+LL E ++ K + TN+ +T L GY + + N L+D+M
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMK 245
Query: 197 PMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
C++E A +RPT + S+L +
Sbjct: 246 --------------------MCWKEKAEERPTFDYLQSVLDD 267
Score = 32.3 bits (72), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
++ + +LG G FG G N +VAVK L + ++ F E L+ LQ LV
Sbjct: 13 ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 71
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFL 120
R+ + +I E+M SL FL
Sbjct: 72 RLYAVVTREEPIYIITEYMAKGSLLDFL 99
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 240
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 241 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 271
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 18 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 76
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 77 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 107
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 241
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 242 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 272
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 19 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 77
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 78 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 108
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 237
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 238 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 268
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 15 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 73
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 74 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 104
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 236
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 237 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 267
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 14 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 72
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 73 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 103
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 235
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 236 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 102
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 15/98 (15%)
Query: 141 HGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQ 200
+G F+IKSDV+SFG+LL E ++ + + TN VI NL + ++ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERG---YRMVRPDNC 235
Query: 201 TEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
E Y +++ C++E DRPT + S+L +
Sbjct: 236 PEELYQLMR-------LCWKERPEDRPTFDYLRSVLED 266
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ + +LG G FG G +VAVK L Q + F E L+ +LQ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPA 124
R+ ++ + I I E+M N SL FL P+
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPS 102
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + S ++F E ++ KL LV++ G C
Sbjct: 33 QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L++E M + L +L
Sbjct: 92 LEQAPICLVFEFMEHGCLSDYL 113
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS V+ ++ + + L P L +
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI---STGFRLYKPRLASTH 252
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y I+ C++E DRP ++ L+
Sbjct: 253 VYQIMNH-------CWKERPEDRPAFSRLLRQLAE 280
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
++G G FG G LN ++VA+K + + E+F E ++ KL LV++ G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
+E+ L+ E M + L +L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL 94
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV+SFGVL+ E S K + +NS + + + + L P L +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--------DISTGFRLYKPRLASTH 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y I+ C+RE DRP ++ L+
Sbjct: 234 VYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 25 FFSLASISAATDNFSMENKLGEGGFGPGKLLNGEQ----VAVKRLSSQSGQGLEEFKNEM 80
F S+ + +M++KLG G +G + ++ VAVK L + + +EEF E
Sbjct: 21 FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 79
Query: 81 MLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
++ +++ NLV+++G C + ++ E+MP + LDY
Sbjct: 80 AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL 119
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 16/19 (84%)
Query: 141 HGVFSIKSDVFSFGVLLLE 159
+ FSIKSDV++FGVLL E
Sbjct: 205 YNTFSIKSDVWAFGVLLWE 223
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 245
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 246 ASEKVYTIM--YS-----CWHEKADERPT 267
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 99 VEKGVKILIYEHMPNKSLDYFL 120
++ +I E+M N L +L
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL 110
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 185 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 236
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 237 ASEKVYTIM--YS-----CWHEKADERPT 258
Score = 31.6 bits (70), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 21 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 80 TKQRPIFIITEYMANGCL 97
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 245
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 246 ASEKVYTIM--YS-----CWHEKADERPT 267
Score = 31.6 bits (70), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 89 TKQRPIFIITEYMANGCL 106
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 230
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 231 ASEKVYTIM--YS-----CWHEKADERPT 252
Score = 31.6 bits (70), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 74 TKQRPIFIITEYMANGCL 91
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 229
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 230 ASEKVYTIM--YS-----CWHEKADERPT 251
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 14 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 73 TKQRPIFIITEYMANGCL 90
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 230
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 231 ASEKVYTIM--YS-----CWHEKADERPT 252
Score = 31.6 bits (70), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 15 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 74 TKQRPIFIITEYMANGCL 91
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 15/89 (16%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPML 199
++ FS KSD+++FGVL+ E S K + TNS T ++ L L P L
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQGL-------RLYRPHL 225
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPT 228
+E Y I+ YS C+ E A +RPT
Sbjct: 226 ASEKVYTIM--YS-----CWHEKADERPT 247
Score = 31.6 bits (70), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 4/78 (5%)
Query: 42 NKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCC 98
+LG G FG GK VA+K + S +EF E ++ L LV++ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 99 VEKGVKILIYEHMPNKSL 116
++ +I E+M N L
Sbjct: 69 TKQRPIFIITEYMANGCL 86
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTL----LGYVIWNLWN-DGSLWDLMD 196
G F+IKS+V+SFG+LL E ++ K + TN+ + GY + + N L+D+M
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMK 244
Query: 197 PMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
C++E A +RPT + S+L +
Sbjct: 245 --------------------MCWKEKAEERPTFDYLQSVLDD 266
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 37.0 bits (84), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 34 ATDNFSMENKLGEGGFG---PGKLLNGEQV-AVKRLSSQSGQG-------LEEFKNEMML 82
A + E ++G+GGFG G+L+ + V A+K L +G +EF+ E+ +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRI 137
++ L N+V++ G ++ E +P L + L D A+ + W ++R+
Sbjct: 77 MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRL 127
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 37.0 bits (84), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 34 ATDNFSMENKLGEGGFG---PGKLLNGEQV-AVKRLSSQSGQG-------LEEFKNEMML 82
A + E ++G+GGFG G+L+ + V A+K L +G +EF+ E+ +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRI 137
++ L N+V++ G ++ E +P L + L D A+ + W ++R+
Sbjct: 77 MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRL 127
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 36.6 bits (83), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 34 ATDNFSMENKLGEGGFG---PGKLLNGEQV-AVKRLSSQSGQG-------LEEFKNEMML 82
A + E ++G+GGFG G+L+ + V A+K L +G +EF+ E+ +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRI 137
++ L N+V++ G ++ E +P L + L D A+ + W ++R+
Sbjct: 77 MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRL 127
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 36.2 bits (82), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 244 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 296
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 297 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 326
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 35.8 bits (81), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 236 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 288
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 289 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 318
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 31 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 91 LGQHENIVNLLGACTHGGPVLVITEY 116
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 35.8 bits (81), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 242 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 294
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 295 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 324
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 35.8 bits (81), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYV 181
AL+G F+IKSDV+SFG+LL E L +K + N+ +L V
Sbjct: 178 ALYGRFTIKSDVWSFGILLTE-LVTKGRVPYPGMNNREVLEQV 219
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 35.8 bits (81), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 242 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 294
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 295 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 324
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 35.8 bits (81), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 230 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 282
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 283 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 312
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 38 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 98 LGQHENIVNLLGACTHGGPVLVITEY 123
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 35.8 bits (81), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 43/199 (21%)
Query: 68 QSGQG---LEEFKNEMMLIAKLQDINLVRIIGCCVEK----GVKILIYEHMPNKSLDYFL 120
Q QG L + + ++ L+ NL+ + G V K G I HM N
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN------- 163
Query: 121 FDPANKGRLGWGTRVRIYALHGV-FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLG 179
NKG W + G +S K DVFS+G++L E ++ +K + ++
Sbjct: 164 ----NKGSAAW---MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM- 215
Query: 180 YVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
W + N P+++ + K ++ C+ ++ + RP+M EIV ++++
Sbjct: 216 ---WAVHN-----GTRPPLIKN-----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 262
Query: 240 IVNLP-------YPQQSAF 251
+ P YP Q +
Sbjct: 263 MRYFPGADEPLQYPCQHSL 281
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 35.8 bits (81), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
V++++SDV+S+G+LL E S N + L+ + L DG + + P +
Sbjct: 238 VYTVQSDVWSYGILLWEIFSLGLNPY-----PGILVNSKFYKLVKDG--YQMAQPAFAPK 290
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
Y I++ C+ T RPT +I S L +
Sbjct: 291 NIYSIMQA-------CWALEPTHRPTFQQICSFLQEQ 320
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 36 DNFSMENKLGEGGFGP---------GKLLNGEQVAVKRLSSQS-GQGLEEFKNEMMLIAK 85
+N LG G FG GK +VAVK L S + E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 86 L-QDINLVRIIGCCVEKGVKILIYEH 110
L Q N+V ++G C G ++I E+
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEY 131
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 35.4 bits (80), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 43/199 (21%)
Query: 68 QSGQG---LEEFKNEMMLIAKLQDINLVRIIGCCVEK----GVKILIYEHMPNKSLDYFL 120
Q QG L + + ++ L+ NL+ + G V K G I HM N
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN------- 162
Query: 121 FDPANKGRLGWGTRVRIYALHGV-FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLG 179
NKG W + G +S K DVFS+G++L E ++ +K + ++
Sbjct: 163 ----NKGSAAW---MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM- 214
Query: 180 YVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNE 239
W + N P L PI ++ C+ ++ + RP+M EIV ++++
Sbjct: 215 ---WAVHNG------TRPPLIKNLPKPI----ESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
Query: 240 IVNLP-------YPQQSAF 251
+ P YP Q +
Sbjct: 262 MRYFPGADEPLQYPCQHSL 280
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 27 SLASISAATDNFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEM 80
SL + +M++KLG G FG ++ G VAVK L + + +EEF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQFG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 58
Query: 81 MLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
++ +++ NLV+++G C + +I E M + LDY
Sbjct: 59 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
Score = 32.3 bits (72), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 187 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 35.0 bits (79), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 184 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 213
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 35.0 bits (79), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 184 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 213
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 35.0 bits (79), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 180 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 209
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 35.0 bits (79), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 177 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 206
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 35.0 bits (79), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 176 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 205
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 35.0 bits (79), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 178 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 207
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 35.0 bits (79), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 35.0 bits (79), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 35.0 bits (79), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 35.0 bits (79), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 35.0 bits (79), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 24/31 (77%), Gaps = 1/31 (3%)
Query: 139 ALHGVFSIKSDVFSFGVLLLETLSSKKNAHF 169
AL+G F+IKSDV+SFG+LL E L++K +
Sbjct: 187 ALYGRFTIKSDVWSFGILLTE-LTTKGRVPY 216
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 35.0 bits (79), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 139 ALHGVFSIKSDVFSFGVLLLE 159
AL+G F+IKSDV+SFG+LL E
Sbjct: 353 ALYGRFTIKSDVWSFGILLTE 373
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 35.0 bits (79), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 139 ALHGVFSIKSDVFSFGVLLLE 159
AL+G F+IKSDV+SFG+LL E
Sbjct: 353 ALYGRFTIKSDVWSFGILLTE 373
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 35.0 bits (79), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 139 ALHGVFSIKSDVFSFGVLLLE 159
AL+G F+IKSDV+SFG+LL E
Sbjct: 436 ALYGRFTIKSDVWSFGILLTE 456
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 35.0 bits (79), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 139 ALHGVFSIKSDVFSFGVLLLE 159
AL+G F+IKSDV+SFG+LL E
Sbjct: 353 ALYGRFTIKSDVWSFGILLTE 373
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 35.0 bits (79), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 15/21 (71%), Positives = 19/21 (90%)
Query: 139 ALHGVFSIKSDVFSFGVLLLE 159
AL+G F+IKSDV+SFG+LL E
Sbjct: 354 ALYGRFTIKSDVWSFGILLTE 374
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 19 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 75
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 76 LVQLLGVCTREPPFYIITEFM 96
Score = 30.8 bits (68), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 194 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 19 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 75
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 76 LVQLLGVCTREPPFYIIIEFM 96
Score = 30.8 bits (68), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 194 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 25 FFSLASISAATDNFSMENKLGEGGFG---------PGKLLNGEQVAVKRLSSQSGQGLEE 75
F +A+ + TD++ + +LG+G F P + + + K+LS++ Q LE
Sbjct: 20 FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE- 78
Query: 76 FKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYE 109
E + L+ N+VR+ E+G L+++
Sbjct: 79 --REARICRLLKHPNIVRLHDSISEEGFHYLVFD 110
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 34.7 bits (78), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 221 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 277
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 278 LVQLLGVCTREPPFYIITEFM 298
Score = 32.0 bits (71), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 396 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 440
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEI 469
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 34.7 bits (78), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 31/144 (21%)
Query: 36 DNFSMENKLGEGGFGPGKLLNGE--------QVAVKRLSS-QSGQGLEEFKNEMMLIAKL 86
++ ++ +GEG FG ++L A+KR+ S +F E+ ++ KL
Sbjct: 15 NDIKFQDVIGEGNFG--QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 72
Query: 87 -QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
N++ ++G C +G L E+ P+ +L FL + R+ F+
Sbjct: 73 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------------RKSRVLETDPAFA 120
Query: 146 IKSDVFSFGVLLLETLSSKKNAHF 169
I + S TLSS++ HF
Sbjct: 121 IANSTAS-------TLSSQQLLHF 137
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 34.7 bits (78), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Score = 30.8 bits (68), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 34.7 bits (78), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 38 FSMENKLGEGGFGP----GKLLNGEQVAVKRLS---SQSGQGLEEFKNEMMLIAKLQDIN 90
FS ++G G FG + N E VA+K++S QS + ++ E+ + KL+ N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 91 LVRIIGCCVEKGVKILIYEH 110
++ GC + + L+ E+
Sbjct: 77 TIQYRGCYLREHTAWLVMEY 96
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 34.7 bits (78), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 18 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 74
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 75 LVQLLGVCTREPPFYIITEFM 95
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 193 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEI 266
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 34.7 bits (78), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 19 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 75
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 76 LVQLLGVCTREPPFYIITEFM 96
Score = 31.2 bits (69), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 194 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 34.7 bits (78), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 27 SLASISAATDNFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEM 80
SL + +M++KLG G +G ++ G VAVK L + + +EEF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 58
Query: 81 MLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
++ +++ NLV+++G C + +I E M + LDY
Sbjct: 59 AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 98
Score = 32.3 bits (72), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 187 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 34.7 bits (78), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 71 LVQLLGVCTREPPFYIITEFM 91
Score = 30.8 bits (68), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 34.3 bits (77), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 31/144 (21%)
Query: 36 DNFSMENKLGEGGFGPGKLLNGE--------QVAVKRLSS-QSGQGLEEFKNEMMLIAKL 86
++ ++ +GEG FG ++L A+KR+ S +F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFG--QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 87 -QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
N++ ++G C +G L E+ P+ +L FL + R+ F+
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------------RKSRVLETDPAFA 130
Query: 146 IKSDVFSFGVLLLETLSSKKNAHF 169
I + S TLSS++ HF
Sbjct: 131 IANSTAS-------TLSSQQLLHF 147
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 34.3 bits (77), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 31/144 (21%)
Query: 36 DNFSMENKLGEGGFGPGKLLNGE--------QVAVKRLSS-QSGQGLEEFKNEMMLIAKL 86
++ ++ +GEG FG ++L A+KR+ S +F E+ ++ KL
Sbjct: 22 NDIKFQDVIGEGNFG--QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 79
Query: 87 -QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
N++ ++G C +G L E+ P+ +L FL + R+ F+
Sbjct: 80 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL------------RKSRVLETDPAFA 127
Query: 146 IKSDVFSFGVLLLETLSSKKNAHF 169
I + S TLSS++ HF
Sbjct: 128 IANSTAS-------TLSSQQLLHF 144
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 34.3 bits (77), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 38 FSMENKLGEGGFGP----GKLLNGEQVAVKRLS---SQSGQGLEEFKNEMMLIAKLQDIN 90
FS ++G G FG + N E VA+K++S QS + ++ E+ + KL+ N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 91 LVRIIGCCVEKGVKILIYEH 110
++ GC + + L+ E+
Sbjct: 116 TIQYRGCYLREHTAWLVMEY 135
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 206 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 257
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 258 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 284
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 214 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 265
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 266 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 292
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 34.3 bits (77), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 34.3 bits (77), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 212 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 263
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 264 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 290
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 213 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 264
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 265 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 291
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 16 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 72
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 73 LVQLLGVCTREPPFYIITEFM 93
Score = 31.2 bits (69), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 191 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 19 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 75
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 76 LVQLLGVCTREPPFYIITEFM 96
Score = 31.2 bits (69), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 194 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 260 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 316
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 317 LVQLLGVCTREPPFYIITEFM 337
Score = 32.0 bits (71), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 435 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 479
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 480 PEGCPEKVYELMRACWQWNPSDRPSFAEI 508
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 214 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 265
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 266 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 292
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 71 LVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
Score = 31.2 bits (69), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 209 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 260
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 261 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 287
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 34.3 bits (77), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 15 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 71
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 72 LVQLLGVCTREPPFYIITEFM 92
Score = 31.2 bits (69), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 190 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 273 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQG-------RRLLQPEYCPDP 324
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 325 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 351
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 213 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 264
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 265 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 291
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 71 LVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
Score = 31.2 bits (69), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 15 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 71
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 72 LVQLLGVCTREPPFYIIIEFM 92
Score = 31.2 bits (69), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 190 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 235 PEGCPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 34.3 bits (77), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 27 SLASISAATDNFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEM 80
SL + +M++KLG G +G ++ G VAVK L + + +EEF E
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEA 58
Query: 81 MLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
++ +++ NLV+++G C + +I E M + LDY
Sbjct: 59 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 187 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 34.3 bits (77), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 14 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Score = 31.2 bits (69), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 189 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 19 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 75
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 76 LVQLLGVCTREPPFYIITEFM 96
Score = 31.2 bits (69), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 194 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 239 PEGCPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 211 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 262
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 263 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 289
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 16 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 72
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 73 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 191 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 232 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 283
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 284 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 310
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 34.3 bits (77), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 214 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 265
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 266 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 292
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 34.3 bits (77), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 23/66 (34%), Positives = 36/66 (54%), Gaps = 9/66 (13%)
Query: 44 LGEGGFGP---GKLLNGE----QVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDINLVRI 94
LGEG FG G L + +VAVK +L + S + +EEF +E + N++R+
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 95 IGCCVE 100
+G C+E
Sbjct: 102 LGVCIE 107
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 34.3 bits (77), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 16 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 72
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 73 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
Score = 31.2 bits (69), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 191 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 236 PEGCPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 34.3 bits (77), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 27 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 83
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKS-LDYF 119
LV+++G C + +I E M + LDY
Sbjct: 84 LVQLLGVCTREPPFYIITEFMTYGNLLDYL 113
Score = 31.2 bits (69), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 202 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 246
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 247 PEGCPEKVYELMRACWQWNPSDRPSFAEI 275
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 34.3 bits (77), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 37 NFSMENKLGEGGFGPGKLLNGE------QVAVKRLSSQSGQGLEEFKNEMMLIAKLQDIN 90
+ +M++KLG G +G ++ G VAVK L + + +EEF E ++ +++ N
Sbjct: 218 DITMKHKLGGGQYG--EVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 274
Query: 91 LVRIIGCCVEKGVKILIYEHM 111
LV+++G C + +I E M
Sbjct: 275 LVQLLGVCTREPPFYIITEFM 295
Score = 32.0 bits (71), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 15/89 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
FSIKSDV++FGVLL E + G + + +++L++ + E
Sbjct: 393 FSIKSDVWAFGVLLWE---------------IATYGMSPYPGIDLSQVYELLEKDYRMER 437
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEI 232
++ + C++ N +DRP+ EI
Sbjct: 438 PEGCPEKVYELMRACWQWNPSDRPSFAEI 466
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 34.3 bits (77), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 19/101 (18%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMD--PML 199
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D D P +
Sbjct: 202 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLDKPDNCPDM 255
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
E L R C++ N RP+ LEI+S + E+
Sbjct: 256 LLE-----LMR------MCWQYNPKMRPSFLEIISSIKEEM 285
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 34.3 bits (77), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 214 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 265
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 266 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 292
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 34.3 bits (77), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 215 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 266
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 267 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 293
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 34.3 bits (77), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 233 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 284
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 285 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 311
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 34.3 bits (77), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 219 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 270
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 271 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 297
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 34.3 bits (77), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 215 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 266
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 267 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 293
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 33.9 bits (76), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 15/94 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ KSDV+SFGVLL E L ++ + + N+ + Y++ L+ P +
Sbjct: 212 FTTKSDVWSFGVLLWE-LMTRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDP 263
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
Y ++ L C+ A RP+ E+VS +S
Sbjct: 264 LYEVM-------LKCWHPKAEMRPSFSELVSRIS 290
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 33.9 bits (76), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 15/91 (16%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+S KSDV++FG+L+ E S K + TNS +L + G L P L ++
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGH--RLYRPHLASDT 233
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVS 234
Y I+ YS C+ E RPT +++S
Sbjct: 234 IYQIM--YS-----CWHELPEKRPTFQQLLS 257
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/84 (28%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 36 DNFSMENKLGEGGFGP---GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLV 92
+ ++ +LG G FG GK VAVK + S +EF E + KL LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 93 RIIGCCVEKGVKILIYEHMPNKSL 116
+ G C ++ ++ E++ N L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCL 90
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 33.9 bits (76), Expect = 0.083, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 19/101 (18%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMD--PML 199
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D D P +
Sbjct: 200 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLDKPDNCPDM 253
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
E L R C++ N RP+ LEI+S + E+
Sbjct: 254 LLE-----LMR------MCWQYNPKMRPSFLEIISSIKEEM 283
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 33.9 bits (76), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 25/101 (24%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+SFG+++ E ++ + ++ +N + + NDG + L PM A
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDG--FRLPTPMDCPSA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVNLP 244
Y ++ + C+++ RP +IVS+L ++++ P
Sbjct: 279 IYQLM-------MQCWQQERARRPKFADIVSIL-DKLIRAP 311
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 33.9 bits (76), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 202 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 253
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 254 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 285
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 33.9 bits (76), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 205 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 256
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 257 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 288
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 33.9 bits (76), Expect = 0.093, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 19/101 (18%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMD--PML 199
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D D P +
Sbjct: 215 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLDKPDNCPDM 268
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
E L R C++ N RP+ LEI+S + E+
Sbjct: 269 LFE-----LMR------MCWQYNPKMRPSFLEIISSIKEEM 298
Score = 28.1 bits (61), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 25 FFSLASI------SAATDNFSMENKLGEGGFG------PGKLLNGE---QVAVKRLS-SQ 68
+FS A + A + +M +LG+G FG ++ E +VA+K ++ +
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 69 SGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
S + EF NE ++ + ++VR++G + ++I E M L +L
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 33.9 bits (76), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 209 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 260
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 261 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 292
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 33.9 bits (76), Expect = 0.096, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 208 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 259
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 260 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 291
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 33.9 bits (76), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 206 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 257
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 258 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 289
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 33.9 bits (76), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 19/101 (18%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMD--PML 199
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D D P +
Sbjct: 215 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLDKPDNCPDM 268
Query: 200 QTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
E L R C++ N RP+ LEI+S + E+
Sbjct: 269 LFE-----LMR------MCWQYNPKMRPSFLEIISSIKEEM 298
Score = 28.1 bits (61), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 25 FFSLASI------SAATDNFSMENKLGEGGFG------PGKLLNGE---QVAVKRLS-SQ 68
+FS A + A + +M +LG+G FG ++ E +VA+K ++ +
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 69 SGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
S + EF NE ++ + ++VR++G + ++I E M L +L
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 33.9 bits (76), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 209 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 260
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 261 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 292
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 33.9 bits (76), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 25/104 (24%)
Query: 35 TDNFSMENKLGEGGFG---------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAK 85
+DN+ ++ +LG+G F G + + K+LS++ Q LE E + K
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 86 LQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
LQ N+VR +++ + +S Y +FD G L
Sbjct: 62 LQHPNIVR-------------LHDSIQEESFHYLVFDLVTGGEL 92
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 25/104 (24%)
Query: 35 TDNFSMENKLGEGGFG---------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAK 85
+DN+ ++ +LG+G F G + + K+LS++ Q LE E + K
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 60
Query: 86 LQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
LQ N+VR +++ + +S Y +FD G L
Sbjct: 61 LQHPNIVR-------------LHDSIQEESFHYLVFDLVTGGEL 91
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 208 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 259
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 260 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 291
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 108
Score = 33.1 bits (74), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 249
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 250 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 281
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++EH+ ++ L F+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM 91
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 15/99 (15%)
Query: 142 GVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQT 201
GVF+ SDV+SFGV+L E +++ + ++ +L +V+ +G L D P
Sbjct: 237 GVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNEQVLRFVM-----EGGLLD--KPDNCP 288
Query: 202 EASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEI 240
+ + +++ C++ N RP+ LEI+S + E+
Sbjct: 289 DMLFELMR-------MCWQYNPKMRPSFLEIISSIKEEM 320
Score = 28.1 bits (61), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 25 FFSLASI------SAATDNFSMENKLGEGGFG------PGKLLNGE---QVAVKRLS-SQ 68
+FS A + A + +M +LG+G FG ++ E +VA+K ++ +
Sbjct: 30 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 89
Query: 69 SGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
S + EF NE ++ + ++VR++G + ++I E M L +L
Sbjct: 90 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 25/104 (24%)
Query: 35 TDNFSMENKLGEGGFG---------PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAK 85
+DN+ ++ +LG+G F G + + K+LS++ Q LE E + K
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 86 LQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
LQ N+VR +++ + +S Y +FD G L
Sbjct: 62 LQHPNIVR-------------LHDSIQEESFHYLVFDLVTGGEL 92
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 44 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 276
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 277 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 308
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/68 (32%), Positives = 34/68 (50%), Gaps = 5/68 (7%)
Query: 42 NKLGEGGFGPGKLL----NGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGC 97
KLGEGGF L+ +G A+KR+ Q EE + E + N++R++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 98 CV-EKGVK 104
C+ E+G K
Sbjct: 95 CLRERGAK 102
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G+++ E +S + ++ TN + +G + L PM A
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV------EEG--YRLPSPMDCPAA 255
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C+++ RP EIV+ML I N
Sbjct: 256 LYQLM-------LDCWQKERNSRPKFDEIVNMLDKLIRN 287
Score = 31.2 bits (69), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 8/91 (8%)
Query: 38 FSMENKLGEGGFGP---GKL-LNGEQ---VAVKRLS-SQSGQGLEEFKNEMMLIAKLQDI 89
++E +G G FG G+L L G++ VA+K L + + +F E ++ +
Sbjct: 24 ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++ + G + +++ E+M N SLD FL
Sbjct: 84 NIIHLEGVVTKSKPVMIVTEYMENGSLDTFL 114
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 34 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E+M N SLD FL
Sbjct: 94 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 125
Score = 33.1 bits (74), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 266
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 267 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 298
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 33.1 bits (74), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 33 AATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKL 86
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 87 QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++EH+ ++ L F+
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM 95
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 249
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 250 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 281
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 17 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E M N SLD FL
Sbjct: 77 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 108
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 33.1 bits (74), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G++L E +S + ++ +N + ++G + L PM A
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------DEG--YRLPPPMDCPAA 278
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
Y ++ L C++++ +RP +IVS+L I N
Sbjct: 279 LYQLM-------LDCWQKDRNNRPKFEQIVSILDKLIRN 310
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 37 NFSMENKLGEGGFGPG-----KLLNGEQVAVKRLSSQSG---QGLEEFKNEMMLIAKLQD 88
N S++ +G G FG KL + ++++V + + G + +F E ++ +
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 89 INLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G + +++ E M N SLD FL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 33.1 bits (74), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 13/21 (61%), Positives = 19/21 (90%)
Query: 142 GVFSIKSDVFSFGVLLLETLS 162
G F+IKSDV+SFG+LL+E ++
Sbjct: 187 GSFTIKSDVWSFGILLMEIVT 207
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 32.7 bits (73), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 27/113 (23%), Positives = 49/113 (43%), Gaps = 25/113 (22%)
Query: 26 FSLASISAATDNFSMENKLGEGGFG---------PGKLLNGEQVAVKRLSSQSGQGLEEF 76
F + + + +DN+ ++ +LG+G F G + + K+LS++ Q LE
Sbjct: 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER- 77
Query: 77 KNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
E + KLQ N+VR +++ + +S Y +FD G L
Sbjct: 78 --EARICRKLQHPNIVR-------------LHDSIQEESFHYLVFDLVTGGEL 115
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 32.7 bits (73), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 13/21 (61%), Positives = 19/21 (90%)
Query: 142 GVFSIKSDVFSFGVLLLETLS 162
G F+IKSDV+SFG+LL+E ++
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 32.7 bits (73), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 13/21 (61%), Positives = 19/21 (90%)
Query: 142 GVFSIKSDVFSFGVLLLETLS 162
G F+IKSDV+SFG+LL+E ++
Sbjct: 344 GSFTIKSDVWSFGILLMEIVT 364
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 32.7 bits (73), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/97 (24%), Positives = 46/97 (47%), Gaps = 4/97 (4%)
Query: 37 NFSMENKLGEGGFGPGKLL--NGEQVAVKRLSSQS--GQGLEEFKNEMMLIAKLQDINLV 92
+ +++ K+G G FG +G VAVK L Q + + EF E+ ++ +L+ N+V
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
+G + ++ E++ SL L + +L
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 28/136 (20%), Positives = 60/136 (44%), Gaps = 14/136 (10%)
Query: 40 MENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIG 96
+ ++G G FG GK V + ++ + + + F+NE+ ++ K + +N++ +G
Sbjct: 40 LSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 97 CCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFSIKS 148
+ + I+ +Y+H+ + + +F + R T + LH I
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR---QTAQGMDYLHAKNIIHR 156
Query: 149 DVFSFGVLLLETLSSK 164
D+ S + L E L+ K
Sbjct: 157 DMKSNNIFLHEGLTVK 172
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 18/64 (28%), Positives = 38/64 (59%), Gaps = 2/64 (3%)
Query: 60 VAVKRLSSQSGQGLE-EFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDY 118
VA+K L+ +G EF +E +++A + +LVR++G C+ ++ L+ + MP+ L
Sbjct: 70 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 128
Query: 119 FLFD 122
++ +
Sbjct: 129 YVHE 132
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 24/97 (24%), Positives = 46/97 (47%), Gaps = 4/97 (4%)
Query: 37 NFSMENKLGEGGFGPGKLL--NGEQVAVKRLSSQS--GQGLEEFKNEMMLIAKLQDINLV 92
+ +++ K+G G FG +G VAVK L Q + + EF E+ ++ +L+ N+V
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 93 RIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
+G + ++ E++ SL L + +L
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 10/82 (12%)
Query: 44 LGEGGFG--------PGKLLNGEQVAVKRLSSQSGQGLE-EFKNEMMLIAKLQDINLVRI 94
LG G FG P VA+K L+ +G EF +E +++A + +LVR+
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 95 IGCCVEKGVKILIYEHMPNKSL 116
+G C+ ++ L+ + MP+ L
Sbjct: 83 LGVCLSPTIQ-LVTQLMPHGCL 103
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 32.3 bits (72), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 30/111 (27%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLSSKKN--------AHFYNTNSLTLLGYVIWNLWNDGSL 191
G+++IKSDV+S+G+LL E S N A+FY L +G
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-------------KLIQNGFK 293
Query: 192 WDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
D P TE Y I++ C+ ++ RP+ + S L ++ +
Sbjct: 294 MD--QPFYATEEIYIIMQS-------CWAFDSRKRPSFPNLTSFLGCQLAD 335
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 15/88 (17%)
Query: 36 DNFSMENKLGEGGFGPGKLLNGE-----------QVAVKRLSSQSGQGLEE-FKNEMMLI 83
+N LG G FG K++N QVAVK L ++ E +E+ ++
Sbjct: 45 ENLEFGKVLGSGAFG--KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEH 110
+L N+V ++G C G LI+E+
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEY 130
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 17/62 (27%), Positives = 34/62 (54%), Gaps = 1/62 (1%)
Query: 60 VAVKRLSS-QSGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDY 118
VA+K L + + + +F +E ++ + N++R+ G + +++ E+M N SLD
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 119 FL 120
FL
Sbjct: 140 FL 141
Score = 31.2 bits (69), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 15/94 (15%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
FS SDV+SFGV++ E L+ + ++ TN + +G + L PM
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------EEG--YRLPAPMGCPH 281
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
A + ++ L C+ ++ RP +IVS+L
Sbjct: 282 ALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 17/62 (27%), Positives = 34/62 (54%), Gaps = 1/62 (1%)
Query: 60 VAVKRLSS-QSGQGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDY 118
VA+K L + + + +F +E ++ + N++R+ G + +++ E+M N SLD
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 119 FL 120
FL
Sbjct: 140 FL 141
Score = 31.2 bits (69), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 15/94 (15%)
Query: 143 VFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTE 202
FS SDV+SFGV++ E L+ + ++ TN + +G + L PM
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------EEG--YRLPAPMGCPH 281
Query: 203 ASYPILKRYSNVDLFCFRENATDRPTMLEIVSML 236
A + ++ L C+ ++ RP +IVS+L
Sbjct: 282 ALHQLM-------LDCWHKDRAQRPRFSQIVSVL 308
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 32.3 bits (72), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 6/78 (7%)
Query: 38 FSMENKLGEGGFGP--GKLLNGEQVAVKRLSSQS----GQGLEEFKNEMMLIAKLQDINL 91
++E +G GGFG G++VAVK Q +E + E L A L+ N+
Sbjct: 9 LTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 92 VRIIGCCVEKGVKILIYE 109
+ + G C+++ L+ E
Sbjct: 69 IALRGVCLKEPNLCLVME 86
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 32.0 bits (71), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 12/106 (11%)
Query: 24 PFFSLASISAATDNFSMENKLGEGGFGPGKL----LNGEQVAV-----KRLSSQSGQGLE 74
P SLA A N+ + LGEG FG KL G++VA+ K L+ QG
Sbjct: 2 PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 58
Query: 75 EFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ E+ + L+ +++++ K I++ E+ N+ DY +
Sbjct: 59 RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV 104
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 32.0 bits (71), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 12/106 (11%)
Query: 24 PFFSLASISAATDNFSMENKLGEGGFGPGKL----LNGEQVAV-----KRLSSQSGQGLE 74
P SLA A N+ + LGEG FG KL G++VA+ K L+ QG
Sbjct: 3 PKSSLAD-GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG-- 59
Query: 75 EFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ E+ + L+ +++++ K I++ E+ N+ DY +
Sbjct: 60 RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV 105
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 32.0 bits (71), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 19/125 (15%)
Query: 122 DPANKGRLGWGTRVRIYALHGV----FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTL 177
DP LG +R A + F+ SDV+S+G+++ E +S + ++ TN
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--- 247
Query: 178 LGYVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
VI + D + L PM A + ++ L C++++ RP +IV+ L
Sbjct: 248 --DVINAIEQD---YRLPPPMDCPSALHQLM-------LDCWQKDRNHRPKFGQIVNTLD 295
Query: 238 NEIVN 242
I N
Sbjct: 296 KMIRN 300
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 31.6 bits (70), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 19/125 (15%)
Query: 122 DPANKGRLGWGTRVRIYALHGV----FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTL 177
DP LG +R A + F+ SDV+S+G+++ E +S + ++ TN
Sbjct: 165 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--- 221
Query: 178 LGYVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLS 237
VI + D + L PM A + ++ L C++++ RP +IV+ L
Sbjct: 222 --DVINAIEQD---YRLPPPMDCPSALHQLM-------LDCWQKDRNHRPKFGQIVNTLD 269
Query: 238 NEIVN 242
I N
Sbjct: 270 KMIRN 274
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 31.2 bits (69), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 12/91 (13%)
Query: 40 MENKLGEGGFG---------PGKLLNGEQVAVKRLSS-QSGQGLEEFKNEMMLIAKLQDI 89
+E +G G FG PGK VA+K L + + EF +E ++ + +
Sbjct: 18 IEEVIGAGEFGEVCRGRLKAPGK--KESCVAIKTLKGGYTERQRREFLSEASIMGQFEHP 75
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G +++ E M N +LD FL
Sbjct: 76 NIIRLEGVVTNSMPVMILTEFMENGALDSFL 106
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G+++ E +S + ++ +N + +G + L PM A
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI------EEG--YRLPPPMDCPIA 241
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
+ ++ L C+++ +DRP +IV+ML I N
Sbjct: 242 LHQLM-------LDCWQKERSDRPKFGQIVNMLDKLIRN 273
Score = 30.0 bits (66), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 38 FSMENKLGEGGFG---PGKL-LNGEQ---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQDI 89
+E +G G FG G+L + G++ VA+K L + + + +F +E ++ +
Sbjct: 10 IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
N++ + G + ++I E+M N SLD FL N GR
Sbjct: 70 NIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF 107
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 31.2 bits (69), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 11 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 70
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 71 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 127
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 128 IHRDLKSNNIFLHEDLTVK 146
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 31.2 bits (69), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 69 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 125
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 126 IHRDLKSNNIFLHEDLTVK 144
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 31.2 bits (69), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G+++ E +S + ++ +N + +G + L PM A
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI------EEG--YRLPPPMDCPIA 247
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
+ ++ L C+++ +DRP +IV+ML I N
Sbjct: 248 LHQLM-------LDCWQKERSDRPKFGQIVNMLDKLIRN 279
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 38 FSMENKLGEGGFG---PGKL-LNGEQ---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQDI 89
+E +G G FG G+L + G++ VA+K L + + + +F +E ++ +
Sbjct: 16 IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
N++ + G + ++I E+M N SLD FL N GR
Sbjct: 76 NIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF 113
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 31.2 bits (69), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 69 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 125
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 126 IHRDLKSNNIFLHEDLTVK 144
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 30.8 bits (68), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 11/93 (11%)
Query: 44 LGEGGFG---PGK-LLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCCV 99
LG+G +G G+ L N ++A+K + + + + E+ L L+ N+V+ +G
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 100 EKGVKILIYEHMPNKSLDYFLFDPANKGRLGWG 132
E G + E +P SL L R WG
Sbjct: 76 ENGFIKIFMEQVPGGSLSALL-------RSKWG 101
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 30.8 bits (68), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 12/91 (13%)
Query: 40 MENKLGEGGFG---------PGKLLNGEQVAVKRLSS-QSGQGLEEFKNEMMLIAKLQDI 89
+E +G G FG PGK VA+K L + + EF +E ++ + +
Sbjct: 20 IEEVIGAGEFGEVCRGRLKAPGK--KESCVAIKTLKGGYTERQRREFLSEASIMGQFEHP 77
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N++R+ G +++ E M N +LD FL
Sbjct: 78 NIIRLEGVVTNSMPVMILTEFMENGALDSFL 108
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 30.8 bits (68), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 15/99 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+S+G+++ E +S + ++ +N + +G + L PM A
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI------EEG--YRLPPPMDCPIA 262
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSNEIVN 242
+ ++ L C+++ +DRP +IV+ML I N
Sbjct: 263 LHQLM-------LDCWQKERSDRPKFGQIVNMLDKLIRN 294
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 10/100 (10%)
Query: 38 FSMENKLGEGGFG---PGKL-LNGEQ---VAVKRLSS-QSGQGLEEFKNEMMLIAKLQDI 89
+E +G G FG G+L + G++ VA+K L + + + +F +E ++ +
Sbjct: 31 IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFLFDPANKGRL 129
N++ + G + ++I E+M N SLD FL N GR
Sbjct: 91 NIIHLEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRF 128
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 30.8 bits (68), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 14 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 74 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 130
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 131 IHRDLKSNNIFLHEDLTVK 149
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 14 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 73
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 74 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 130
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 131 IHRDLKSNNIFLHEDLTVK 149
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 11/97 (11%)
Query: 33 AATDNFSMENKLGEGGFGPGKL----LNGEQVAV-----KRLSSQSGQGLEEFKNEMMLI 83
A N+ + LGEG FG KL G++VA+ K L+ QG + E+ +
Sbjct: 1 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 84 AKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
L+ +++++ K I++ E+ N+ DY +
Sbjct: 59 RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV 95
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 11/93 (11%)
Query: 44 LGEGGFG---PGK-LLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCCV 99
LG+G +G G+ L N ++A+K + + + + E+ L L+ N+V+ +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 100 EKGVKILIYEHMPNKSLDYFLFDPANKGRLGWG 132
E G + E +P SL L R WG
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-------RSKWG 115
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 11/97 (11%)
Query: 33 AATDNFSMENKLGEGGFGPGKL----LNGEQVAV-----KRLSSQSGQGLEEFKNEMMLI 83
A N+ + LGEG FG KL G++VA+ K L+ QG + E+ +
Sbjct: 5 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 84 AKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
L+ +++++ K I++ E+ N+ DY +
Sbjct: 63 RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV 99
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 30.8 bits (68), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 29 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 88
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 89 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 145
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 146 IHRDLKSNNIFLHEDLTVK 164
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 30.8 bits (68), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 36 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 95
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 96 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 152
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 153 IHRDLKSNNIFLHEDLTVK 171
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 30.8 bits (68), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 18/58 (31%), Positives = 32/58 (55%), Gaps = 6/58 (10%)
Query: 42 NKLGEGGFGPGKLL----NGEQVAVKRL--SSQSGQGLEEFKNEMMLIAKLQDINLVR 93
K+GEG FG L+ +G Q +K + S S + EE + E+ ++A ++ N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 30.4 bits (67), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 37 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 97 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 153
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 154 IHRDLKSNNIFLHEDLTVK 172
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 30.4 bits (67), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 60/139 (43%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 37 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 96
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + + I+ +Y H+ + + + R T + LH
Sbjct: 97 FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 153
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 154 IHRDLKSNNIFLHEDLTVK 172
>pdb|3S1S|A Chain A, Characterization And Crystal Structure Of The Type Iig
Restriction Endonuclease Bpusi
Length = 878
Score = 30.4 bits (67), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 191 LWDLMDPMLQTEASYPILKRYSNVDLFCFRENAT 224
LWDL+D + + YP L++ + ++ F E+AT
Sbjct: 630 LWDLLDESVPRDWLYPALRKVNEINTPIFNEDAT 663
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 30.4 bits (67), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 30/139 (21%), Positives = 59/139 (42%), Gaps = 14/139 (10%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68
Query: 94 IIGCCVEKGVKIL--------IYEHMPNKSLDYFLFDPANKGRLGWGTRVRIYALHGVFS 145
+G + I+ +Y H+ + + + R T + LH
Sbjct: 69 FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIAR---QTAQGMDYLHAKSI 125
Query: 146 IKSDVFSFGVLLLETLSSK 164
I D+ S + L E L+ K
Sbjct: 126 IHRDLKSNNIFLHEDLTVK 144
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 39/95 (41%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+ F V + E LS K F+ N + + G L P L
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGD--RLPKPDLCPPV 242
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y ++ R C+ + +DRP E+V LS+
Sbjct: 243 LYTLMTR-------CWDYDPSDRPRFTELVCSLSD 270
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/73 (23%), Positives = 38/73 (52%), Gaps = 3/73 (4%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 13 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 72
Query: 94 IIGCCVEKGVKIL 106
+G + + I+
Sbjct: 73 FMGYSTKPQLAIV 85
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 30.0 bits (66), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 21 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 81 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 118
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+ F V + E LS K F+ N ++G + G L P L
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVL-----EKGD--RLPKPDLCPPV 238
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y ++ R C+ + +DRP E+V LS+
Sbjct: 239 LYTLMTR-------CWDYDPSDRPRFTELVCSLSD 266
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 39/95 (41%), Gaps = 15/95 (15%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
F+ SDV+ F V + E LS K F+ N + + G L P L
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI------GVLEKGD--RLPKPDLCPPV 254
Query: 204 SYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
Y ++ R C+ + +DRP E+V LS+
Sbjct: 255 LYTLMTR-------CWDYDPSDRPRFTELVCSLSD 282
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDY 118
N+V+++ + L++E + D+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQDLKDF 91
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 17 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 77 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 114
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 20 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 80 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 117
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 110
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 43/84 (51%), Gaps = 12/84 (14%)
Query: 60 VAVKRLSSQSG-QGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LD 117
V +K + +SG Q + + M+ I L ++VR++G C ++ L+ +++P S LD
Sbjct: 63 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD 121
Query: 118 YFLFDPANKGRLG------WGTRV 135
+ ++G LG WG ++
Sbjct: 122 HVR---QHRGALGPQLLLNWGVQI 142
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 43/84 (51%), Gaps = 12/84 (14%)
Query: 60 VAVKRLSSQSG-QGLEEFKNEMMLIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKS-LD 117
V +K + +SG Q + + M+ I L ++VR++G C ++ L+ +++P S LD
Sbjct: 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD 103
Query: 118 YFLFDPANKGRLG------WGTRV 135
+ ++G LG WG ++
Sbjct: 104 HVR---QHRGALGPQLLLNWGVQI 124
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFGPGKLLNG-----------EQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D + LGEG FG L +VAVK L S + + L + +EM ++
Sbjct: 28 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 88 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/22 (59%), Positives = 18/22 (81%)
Query: 141 HGVFSIKSDVFSFGVLLLETLS 162
+G +S +SDV+SFG+LL ET S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
Score = 28.1 bits (61), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 36 DNFSMENKLGEGGFGP---GKL-LNGEQVAVKRLSSQSGQGLE-EFKNEMMLIAKLQDIN 90
++ + ++G G FG G+L + VAVK L+ +F E ++ + N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 91 LVRIIGCCVEKGVKILIYE 109
+VR+IG C +K ++ E
Sbjct: 174 IVRLIGVCTQKQPIYIVME 192
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/22 (59%), Positives = 18/22 (81%)
Query: 141 HGVFSIKSDVFSFGVLLLETLS 162
+G +S +SDV+SFG+LL ET S
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310
Score = 28.1 bits (61), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 36 DNFSMENKLGEGGFGP---GKL-LNGEQVAVKRLSSQSGQGLE-EFKNEMMLIAKLQDIN 90
++ + ++G G FG G+L + VAVK L+ +F E ++ + N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 91 LVRIIGCCVEKGVKILIYE 109
+VR+IG C +K ++ E
Sbjct: 174 IVRLIGVCTQKQPIYIVME 192
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/61 (24%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 38 FSMENKLGEGGFGPGKLL--NGEQV--AVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+++EN +G G +G K+ G ++ A K++ + ++ FK E+ ++ L N++R
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 94 I 94
+
Sbjct: 71 L 71
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 63 NIVKLLDVIHTENKLYLVFE 82
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 217 VYTIQSDVWSFGVLLWEIFS 236
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 63 NIVKLLDVIHTENKLYLVFE 82
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL 86
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 217 VYTIQSDVWSFGVLLWEIFS 236
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 62 NIVKLLDVIHTENKLYLVFE 81
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL 87
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 17/73 (23%), Positives = 38/73 (52%), Gaps = 3/73 (4%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 94 IIGCCVEKGVKIL 106
+G + + I+
Sbjct: 85 FMGYSTKPQLAIV 97
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 217 VYTIQSDVWSFGVLLWEIFS 236
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 33 AATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKL 86
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 87 QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM 95
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 6/82 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 88 DINLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFE 82
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 62 NIVKLLDVIHTENKLYLVFE 81
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 29.6 bits (65), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 90 NLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 70 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL 85
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 228 VYTIQSDVWSFGVLLWEIFS 247
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 6/80 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 90 NLVRIIGCCVEKGVKILIYE 109
N+V+++ + L++E
Sbjct: 64 NIVKLLDVIHTENKLYLVFE 83
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 217 VYTIQSDVWSFGVLLWEIFS 236
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 222 VYTIQSDVWSFGVLLWEIFS 241
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 88 DINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 222 VYTIQSDVWSFGVLLWEIFS 241
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 34 ATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQ 87
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 88 DINLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL 84
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 226 VYTIQSDVWSFGVLLWEIFS 245
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/61 (24%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 38 FSMENKLGEGGFGPGKLL--NGEQV--AVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
+++EN +G G +G K+ G ++ A K++ + ++ FK E+ ++ L N++R
Sbjct: 28 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 94 I 94
+
Sbjct: 88 L 88
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 33 AATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKL 86
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 87 QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 64 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 276 VYTIQSDVWSFGVLLWEIFS 295
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 33 AATDNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKL 86
+ +NF K+GEG +G L GE VA+K RL +++ E+ L+ +L
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 87 QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
N+V+++ + L++E + ++ L F+
Sbjct: 63 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 278 VYTIQSDVWSFGVLLWEIFS 297
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 271 VYTIQSDVWSFGVLLWEIFS 290
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 269 VYTIQSDVWSFGVLLWEIFS 288
>pdb|1T10|A Chain A, Phosphoglucose Isomerase From Leishmania Mexicana In
Complex With Substrate D-Fructose-6-Phosphate
Length = 605
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 179 GYVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
G I+N+ N G + P++ TEA P KR DL CF + D M E++ ++
Sbjct: 193 GKSIYNIVNIGIGGSDLGPVMVTEALKPFSKR----DLHCFFVSNVDGTHMAEVLKQVNL 248
Query: 239 E 239
E
Sbjct: 249 E 249
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 245 MEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 17/58 (29%), Positives = 30/58 (51%), Gaps = 8/58 (13%)
Query: 44 LGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGC 97
+G GGFG ++G+ +KR+ + E+ + E+ +AKL +N+V GC
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 13/20 (65%), Positives = 17/20 (85%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
V++I+SDV+SFGVLL E S
Sbjct: 263 VYTIQSDVWSFGVLLWEIFS 282
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 236 MEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 219 MEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 225 MEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 235 MEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 17/23 (73%)
Query: 140 LHGVFSIKSDVFSFGVLLLETLS 162
+ G+F+ K+D +SFGVLL E S
Sbjct: 210 MEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|1Q50|A Chain A, Phosphoglucose Isomerase From Leishmania Mexicana
Length = 561
Score = 29.3 bits (64), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 179 GYVIWNLWNDGSLWDLMDPMLQTEASYPILKRYSNVDLFCFRENATDRPTMLEIVSMLSN 238
G I+N+ N G + P++ TEA P KR DL CF + D M E++ ++
Sbjct: 150 GKSIYNIVNIGIGGSDLGPVMVTEALKPFSKR----DLHCFFVSNVDGTHMAEVLKQVNL 205
Query: 239 E 239
E
Sbjct: 206 E 206
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 16/63 (25%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 37 NFSMENKLGEGGFG---PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVR 93
++ ++G G FG GK V + +++ + Q L+ FKNE+ ++ K + +N++
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 94 IIG 96
+G
Sbjct: 85 FMG 87
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 35 TDNFSMENKLGEGGFGPGKLLNGEQ----VAVKRLSSQSGQGLEE-FKNEMMLIAKLQDI 89
+D + + +G G FG +L+ +Q VAVK + + G+ ++E K E++ L+
Sbjct: 17 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHP 74
Query: 90 NLVR 93
N+VR
Sbjct: 75 NIVR 78
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 35 TDNFSMENKLGEGGFGPGKLLNGEQ----VAVKRLSSQSGQGLEE-FKNEMMLIAKLQDI 89
+D + + +G G FG +L+ +Q VAVK + + G+ ++E K E++ L+
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHP 75
Query: 90 NLVR 93
N+VR
Sbjct: 76 NIVR 79
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 35 TDNFSMENKLGEGGFGPGKLLNGEQ----VAVKRLSSQSGQGLEE-FKNEMMLIAKLQDI 89
+D + + +G G FG +L+ +Q VAVK + + G+ ++E K E++ L+
Sbjct: 18 SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHP 75
Query: 90 NLVR 93
N+VR
Sbjct: 76 NIVR 79
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 10/99 (10%)
Query: 32 SAATDNFSMENKLGEGGF---------GPGKLLNGEQVAVKRL-SSQSGQGLEEFKNEMM 81
S D++ M +LG G F G GK + + +RL SS+ G EE + E+
Sbjct: 22 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 82 LIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
++ +++ N++ + K +LI E + L FL
Sbjct: 82 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 120
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFGVL+ E S
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 10/99 (10%)
Query: 32 SAATDNFSMENKLGEGGF---------GPGKLLNGEQVAVKRLSS-QSGQGLEEFKNEMM 81
S D++ M +LG G F G GK + + +RLSS + G EE + E+
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 82 LIAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
++ +++ N++ + K +LI E + L FL
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 99
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 19/72 (26%), Positives = 37/72 (51%), Gaps = 4/72 (5%)
Query: 44 LGEGGFGP----GKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGCCV 99
LG G FG + G ++A K + ++ + EE KNE+ ++ +L NL+++
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 100 EKGVKILIYEHM 111
K +L+ E++
Sbjct: 157 SKNDIVLVMEYV 168
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 29.3 bits (64), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 35 TDNFSMENKLGEGGFGPGKLLNGEQ----VAVKRLSSQSGQGLEE-FKNEMMLIAKLQDI 89
+D + + +G G FG +L+ +Q VAVK + + G+ ++E K E++ L+
Sbjct: 18 SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHP 75
Query: 90 NLVR 93
N+VR
Sbjct: 76 NIVR 79
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 29.3 bits (64), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 11/88 (12%)
Query: 38 FSMENKLGEGGFGPGKLLN------GEQVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQDIN 90
+ M+ +LG GGF G +L GEQVA+K+ + S + E + E+ ++ KL N
Sbjct: 16 WEMKERLGTGGF--GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKSLDY 118
+V V G++ L +P +++Y
Sbjct: 74 VVSARE--VPDGLQKLAPNDLPLLAMEY 99
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 28.9 bits (63), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 17/95 (17%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+ K+D++SFG+ +E + H Y + +L L ND P L+T
Sbjct: 199 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQND-------PPSLETGV 246
Query: 204 S-YPILKRYS----NVDLFCFRENATDRPTMLEIV 233
+LK+Y + C +++ RPT E++
Sbjct: 247 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 11/88 (12%)
Query: 38 FSMENKLGEGGFGPGKLLN------GEQVAVKRLSSQ-SGQGLEEFKNEMMLIAKLQDIN 90
+ M+ +LG GGF G +L GEQVA+K+ + S + E + E+ ++ KL N
Sbjct: 17 WEMKERLGTGGF--GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 91 LVRIIGCCVEKGVKILIYEHMPNKSLDY 118
+V V G++ L +P +++Y
Sbjct: 75 VVSARE--VPDGLQKLAPNDLPLLAMEY 100
>pdb|1B65|A Chain A, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
pdb|1B65|B Chain B, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
pdb|1B65|C Chain C, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
pdb|1B65|D Chain D, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
pdb|1B65|E Chain E, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
pdb|1B65|F Chain F, Structure Of L-Aminopeptidase D-Ala-EsteraseAMIDASE FROM
Ochrobactrum Anthropi, A Prototype For The Serine
Aminopeptidases, Reveals A New Variant Among The Ntn
Hydrolase Fold
Length = 375
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 21/77 (27%), Positives = 31/77 (40%), Gaps = 1/77 (1%)
Query: 114 KSLDYFLFDPANKGRLGWGTRVRIYALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTN 173
K+LD P +G G GT + Y G S V FG T+ + A+ +
Sbjct: 165 KALDNVASGPVQEGNCGGGTGMITYGFKGGTGTASRVVEFGGRSF-TIGALVQANHGQRD 223
Query: 174 SLTLLGYVIWNLWNDGS 190
LT+ G + DG+
Sbjct: 224 WLTIAGVPVGQHMRDGT 240
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 16/19 (84%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
F+ KSDV+SFGVLL E L+
Sbjct: 205 FTTKSDVWSFGVLLWELLT 223
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 16/58 (27%), Positives = 30/58 (51%), Gaps = 8/58 (13%)
Query: 44 LGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRIIGC 97
+G GGFG ++G+ ++R+ + E+ + E+ +AKL +N+V GC
Sbjct: 20 IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 73
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 28.9 bits (63), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFG+LL E S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 28.9 bits (63), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 17/95 (17%)
Query: 144 FSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEA 203
+ K+D++SFG+ +E + H Y + +L L ND P L+T
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQND-------PPSLETGV 251
Query: 204 S-YPILKRYS----NVDLFCFRENATDRPTMLEIV 233
+LK+Y + C +++ RPT E++
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 22 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 82 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 13/21 (61%), Positives = 15/21 (71%)
Query: 142 GVFSIKSDVFSFGVLLLETLS 162
FS KSDV+SFG+LL E S
Sbjct: 180 AAFSTKSDVWSFGILLWEIYS 200
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 28.5 bits (62), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 27 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 87 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
>pdb|1ZO0|A Chain A, Nmr Structure Of Antizyme Isoform 1 From Rat
Length = 126
Score = 28.5 bits (62), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 10/98 (10%)
Query: 159 ETLSSKKNAHFYNTNSLTLLGYVIWN-LWNDGSLWDLMD--PMLQ-TEASYPILKRYSNV 214
E S+ K +LT V W +WN G L+ + P+ + ++ S+ L ++
Sbjct: 13 EPTSNDKTRVLSIQCTLTEAKQVTWRAVWNGGGLYIELPAGPLPEGSKDSFAALLEFAEE 72
Query: 215 DL------FCFRENATDRPTMLEIVSMLSNEIVNLPYP 246
L CF +N DR +L S L EIV +P
Sbjct: 73 QLRADHVFICFPKNREDRAALLRTFSFLGFEIVRPGHP 110
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 28.5 bits (62), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 24 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I E+ +L +L
Sbjct: 84 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 28.5 bits (62), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFG+LL E S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 28.5 bits (62), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 13/19 (68%), Positives = 15/19 (78%)
Query: 144 FSIKSDVFSFGVLLLETLS 162
FS KSDV+SFG+LL E S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 28.5 bits (62), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 36 DNFSMENKLGEGGF---------GPGKLLNGEQVAVKRLSS-QSGQGLEEFKNEMMLIAK 85
D++ M +LG G F G GK + + +RLSS + G EE + E+ ++ +
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 86 LQDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
++ N++ + K +LI E + L FL
Sbjct: 72 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 106
>pdb|2GSI|B Chain B, Crystal Structure Of A Murine Fab In Complex With An 11
Residue Peptide Derived From Staphylococcal Nuclease
pdb|2GSI|D Chain D, Crystal Structure Of A Murine Fab In Complex With An 11
Residue Peptide Derived From Staphylococcal Nuclease
pdb|2GSI|F Chain F, Crystal Structure Of A Murine Fab In Complex With An 11
Residue Peptide Derived From Staphylococcal Nuclease
pdb|2GSI|H Chain H, Crystal Structure Of A Murine Fab In Complex With An 11
Residue Peptide Derived From Staphylococcal Nuclease
Length = 221
Score = 28.5 bits (62), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 27/118 (22%), Positives = 46/118 (38%), Gaps = 14/118 (11%)
Query: 98 CVEKGVKILIY-----EHMPNKSLDYF-LFDPANKGRLGWGTRVRIYALHGVFSIKSDVF 151
C G I Y + P + L++ DP N G + G ++ +D
Sbjct: 21 CTASGFNIKDYYMYWVKLRPEQGLEWIGWIDPEN------GDTEYVPTFQGKVTMTADTS 74
Query: 152 S-FGVLLLETLSSKKNAHFY-NTNSLTLLGYVIWNLWNDGSLWDLMDPMLQTEASYPI 207
S L L +L+S+ A +Y N +T++GY + W G+ + YP+
Sbjct: 75 SNTAYLQLSSLTSEDTAVYYCNAGVITMMGYQAMDYWGQGTTVTTSSAKTTPPSVYPL 132
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 28.5 bits (62), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 12/20 (60%), Positives = 16/20 (80%)
Query: 143 VFSIKSDVFSFGVLLLETLS 162
++S KSDV+S+GVLL E S
Sbjct: 277 IYSTKSDVWSYGVLLWEIFS 296
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 28.1 bits (61), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 29/139 (20%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 27 SLASISAATDNFSMENKLGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMML 82
S+ S+ ++ K+G+G G + G++VA+++++ Q E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSL-DYFLFDPANKGRLGWGTRVRIYA-- 139
+ + ++ N+V + + ++ E++ SL D ++G++ R + A
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 140 -LHGVFSIKSDVFSFGVLL 157
LH I D+ S +LL
Sbjct: 131 FLHSNQVIHRDIKSDNILL 149
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 28.1 bits (61), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 44 LGEGGFGPGK----LLNGEQV----AVKRL-SSQSGQGLEEFKNEMMLIAKLQDINLVRI 94
LG G FG + GE+V A+K L + S + +E +E ++A + + ++ R+
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 95 IGCCVEKGVKILIYEHMP-NKSLDYFLFDPANKGR---LGWGTRV 135
+G C+ V+ LI + MP LDY N G L W ++
Sbjct: 84 LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 28.1 bits (61), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 29/139 (20%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 27 SLASISAATDNFSMENKLGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMML 82
S+ S+ ++ K+G+G G + G++VA+++++ Q E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSL-DYFLFDPANKGRLGWGTRVRIYA-- 139
+ + ++ N+V + + ++ E++ SL D ++G++ R + A
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 140 -LHGVFSIKSDVFSFGVLL 157
LH I D+ S +LL
Sbjct: 131 FLHSNQVIHRDIKSDNILL 149
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 28.1 bits (61), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 29/139 (20%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 27 SLASISAATDNFSMENKLGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMML 82
S+ S+ ++ K+G+G G + G++VA+++++ Q E NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSL-DYFLFDPANKGRLGWGTRVRIYA-- 139
+ + ++ N+V + + ++ E++ SL D ++G++ R + A
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 140 -LHGVFSIKSDVFSFGVLL 157
LH I D+ S +LL
Sbjct: 131 FLHSNQVIHRDIKSDNILL 149
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 28.1 bits (61), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 29/139 (20%), Positives = 64/139 (46%), Gaps = 8/139 (5%)
Query: 27 SLASISAATDNFSMENKLGEGGFG----PGKLLNGEQVAVKRLSSQSGQGLEEFKNEMML 82
S+ S+ ++ K+G+G G + G++VA+++++ Q E NE+++
Sbjct: 12 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 83 IAKLQDINLVRIIGCCVEKGVKILIYEHMPNKSL-DYFLFDPANKGRLGWGTRVRIYA-- 139
+ + ++ N+V + + ++ E++ SL D ++G++ R + A
Sbjct: 72 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 131
Query: 140 -LHGVFSIKSDVFSFGVLL 157
LH I D+ S +LL
Sbjct: 132 FLHSNQVIHRDIKSDNILL 150
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 28.1 bits (61), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 25/56 (44%), Gaps = 2/56 (3%)
Query: 126 KGRLGWGTRVRIYALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYV 181
K R+G + L G + K DV+S GV+L LS FY N +L V
Sbjct: 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRV 234
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 28.1 bits (61), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 25/56 (44%), Gaps = 2/56 (3%)
Query: 126 KGRLGWGTRVRIYALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYV 181
K R+G + L G + K DV+S GV+L LS FY N +L V
Sbjct: 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRV 234
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 27.7 bits (60), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 25/56 (44%), Gaps = 2/56 (3%)
Query: 126 KGRLGWGTRVRIYALHGVFSIKSDVFSFGVLLLETLSSKKNAHFYNTNSLTLLGYV 181
K R+G + L G + K DV+S GV+L LS FY N +L V
Sbjct: 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRV 234
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 27.7 bits (60), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 29/56 (51%), Gaps = 4/56 (7%)
Query: 43 KLGEGGFGPGKLL----NGEQVAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRI 94
K+GEG G L +G QVAVK + + Q E NE++++ Q N+V +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 27.7 bits (60), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+ RL +++ E+ L+ +L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 90 NLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL 84
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 27.7 bits (60), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 36 DNFSMENKLGEGGFG----PGKLLNGEQVAVK--RLSSQSGQGLEEFKNEMMLIAKLQDI 89
+NF K+GEG +G L GE VA+ RL +++ E+ L+ +L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVRIIGCCVEKGVKILIYEHM 111
N+V+++ + L++E +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL 83
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 27.3 bits (59), Expect = 8.1, Method: Compositional matrix adjust.
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 13/98 (13%)
Query: 36 DNFSMENKLGEGGFG-----------PGKLLNGEQVAVKRLSSQSGQ-GLEEFKNEMMLI 83
D ++ LGEG FG K VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 84 AKL-QDINLVRIIGCCVEKGVKILIYEHMPNKSLDYFL 120
+ + N++ ++G C + G +I + +L +L
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 27.3 bits (59), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 22/45 (48%)
Query: 118 YFLFDPANKGRLGWGTRVRIYALHGVFSIKSDVFSFGVLLLETLS 162
+F K ++G + LHG + K DV+S GV+L LS
Sbjct: 178 HFEASKKXKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLS 222
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 27.3 bits (59), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 4/57 (7%)
Query: 43 KLGEGGFGPG-KLLNGEQ---VAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRII 95
+LG+G FG K N E A K + ++S + LE++ E+ ++A N+V+++
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 27.3 bits (59), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 4/57 (7%)
Query: 43 KLGEGGFGPG-KLLNGEQ---VAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRII 95
+LG+G FG K N E A K + ++S + LE++ E+ ++A N+V+++
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 27.3 bits (59), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 17/57 (29%), Positives = 32/57 (56%), Gaps = 4/57 (7%)
Query: 43 KLGEGGFGPG-KLLNGEQ---VAVKRLSSQSGQGLEEFKNEMMLIAKLQDINLVRII 95
+LG+G FG K N E A K + ++S + LE++ E+ ++A N+V+++
Sbjct: 44 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.137 0.410
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,232,366
Number of Sequences: 62578
Number of extensions: 287317
Number of successful extensions: 1433
Number of sequences better than 100.0: 377
Number of HSP's better than 100.0 without gapping: 211
Number of HSP's successfully gapped in prelim test: 166
Number of HSP's that attempted gapping in prelim test: 902
Number of HSP's gapped (non-prelim): 628
length of query: 253
length of database: 14,973,337
effective HSP length: 97
effective length of query: 156
effective length of database: 8,903,271
effective search space: 1388910276
effective search space used: 1388910276
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 50 (23.9 bits)